Literature DB >> 3068232

Studies on the human retinoblastoma susceptibility gene.

W H Lee1, R Bookstein, E Y Lee.   

Abstract

The retinoblastoma susceptibility (RB) gene is unique among other cloned cancer genes because its causal role in a human cancer, retinoblastoma, was established by classical genetic methods before its isolation. Earlier hypotheses and experimental data suggested that inactivation of a gene in chromosome band 13q14 resulted in retinoblastoma formation. A gene in this region was identified as the RB gene on the basis of mutations found specifically in retinoblastoma tumors; however, its proposed biological activity in suppressing neoplasia has yet to be demonstrated. The RB gene product was identified as a nuclear phosphoprotein of 110 kD associated with DNA binding activity, suggesting that the RB protein may regulate other genes. Probes for the RB gene and gene product will be useful for genetic diagnosis of retinoblastoma susceptibility in affected families; for direct detection of mutant RB alleles; and, potentially, for genetic diagnosis of susceptibility to osteosarcoma and other tumors tentatively linked to RB-gene dysfunction. Continued study of the RB gene should yield further insight into mechanisms of oncogenesis, development, and gene regulation.

Entities:  

Mesh:

Year:  1988        PMID: 3068232     DOI: 10.1002/jcb.240380309

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  Perturbation of the p53 response by human papillomavirus type 16 E7.

Authors:  E S Hickman; S Bates; K H Vousden
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.

Authors:  J Y Shew; B T Lin; P L Chen; B Y Tseng; T L Yang-Feng; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Domains of E1A that bind p105Rb, p130, and p300 are required to block nerve growth factor-induced neurite growth in PC12 cells.

Authors:  D Kalman; K Whittaker; J M Bishop; P H O'Lague
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

5.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells.

Authors:  G A Evans; L M Wahl; W L Farrar
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

7.  Retinoblastoma protein phosphorylation does not require activation of p34CDC2 protein kinase.

Authors:  G A Evans; W L Farrar
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

8.  Molecular karyotype of sporadic unilateral retinoblastoma tumors.

Authors:  Arupa Ganguly; Kim E Nichols; Gregory Grant; Eric Rappaport; Carol Shields
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

9.  Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line.

Authors:  R Bookstein; E Y Lee; A Peccei; W H Lee
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

10.  Structure of the human retinoblastoma gene.

Authors:  F D Hong; H J Huang; H To; L J Young; A Oro; R Bookstein; E Y Lee; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.